13648 Federal Register / Vol. 76, No. 49 / Monday, March 14, 2011 / Notices 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Heather Bowles, 

Risk Factor Monitoring and Methods 

Branch, Division of Cancer Control and 

Population Sciences, National Cancer 

Institute, 6130 Executive Blvd MSC 

7344, Bethesda, MD 20892–7335 or call 

non-toll-free number 301–496–7344 or 

e-mail your request, including your 

address to: bowleshr@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: March 8, 2011. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2011–5800 Filed 3–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; Process Evaluation of the 

NIH Roadmap Epigenomics Program 

Summary: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Institute of Drug Abuse 

(NIDA), the National Institutes of Health 

(NIH), will publish periodic summaries 

of proposed projects to be submitted to 

the Office of Management and Budget 

(OMB) for review and approval. 

Proposed Collection 

Title: Process Evaluation of the NIH 

Roadmap Epigenomics Program. 

Type of Information Collection 

Request: New. 

Need and Use of Information 

Collection: The proposed information 

collection is essential to the process 

evaluation of the NIH Roadmap 

Epigenomics Program. The process 

evaluation is a requirement of each 

awardee funded under the NIH 

Roadmap Epigenomics Program. This 

participation requirement is stated in 

the program’s Requests for Applications. 

This evaluation study, a mixedmethods study which uses secondary 

source documentation and information 

from tracking and monitoring systems 

along with primary data to assess 

program process and progress, is nonexperimental. The assessment is based 

on secondary source information, with 

primary source information collection 

added to augment the reliability and 

internal validity. The primary data 

collection uses information categories 

that genuinely tap added distinctions 

and opinions that relate to it to build the 

weight of evidence from first-hand 

sources and substantiate the initial 

hypotheses about the program 

phenomenon and its differences from a 

typical research portfolio of individual 

and insular projects. 

The synthesized results across 

primary and secondary data sources will 

provide critical insights on 

transformativeness of high-impact, 

trans-NIH programs and contribute 

important information about the 

synergies and collaborations in multicomponent scientific research. It will 

also identify areas for program 

improvement and lessons learned that 

might be useful to other research 

programs of the Agency. 

To reduce response bias and to make 

the survey as accessible as possible to 

busy principal investigators, the survey 

will be Web-based. 

Frequency of Response: Once. 

Affected Public: Principal 

Investigators of the program at not-forprofit institutions. 

Type of Respondents: Principal 

Investigators. 

The annual reporting burden is as 

follows: 

Estimated number of Respondents: 

53. 

Estimated Number of Responses per 

Respondent: 1. 

Average Burden Hours Per Response: 

0.33. 

Estimated Total Annual Burden 

Hours Requested: 17.49. 

The annualized cost to respondents is 

estimated at: $891.99. 

There are no Capital Costs, Operating 

Costs and/or Maintenance Costs to 

report. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of respondents 

Frequency of 

responses per 

respondent 

Average burden hours 

per response 

Annual burden 

hours 

requested 

Principal Investigators ......................................................................... 53 1 0.33 (20 minutes) ....... 17.49 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

For Further Information Contact: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Genevieve 

deAlmeida-Morris, PhD, M.P.H., Project 

Officer, Office of Science Policy and 

Communications, NIH/NIDA, NSC— 

Neuroscience Center, 5229, 6001 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 76, No. 49 / Monday, March 14, 2011 / Notices 13649 

Executive Blvd., Rockville, MD 20852 or 

call non-toll-free number 301–594–6802 

or e-mail your request including your 

address to: dealmeig@nida.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60-days of the date of 

this publication. 

Dated: March 8, 2011. 

Mary Affeldt, 

Executive Officer (OM Director), NIDA. 

[FR Doc. 2011–5786 Filed 3–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Martin Delaney 

Collaboratory: Towards an HIV–1 Cure. 

Date: April 4–6, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Silver Spring, 8727 Colesville 

Road, Silver Spring, MD 20910. 

Contact Person: Jay Bruce Sundstrom, PhD, 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC–7616, Room 3119, 

Bethesda, MD 20892–7616, 301–496–7042, 

sundstromj@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 8, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–5798 Filed 3–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Molecular and 

Cellular Controls of Placental Metabolism. 

Date: April 4, 2011. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, 5B01, Rockville, MD 

20852, (Telephone Conference Call) 

Contact Person: Neelakanta Ravindranath, 

PhD, Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5B01, Bethesda, MD 20892, 

301–496–1485, ravindm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: March 8, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–5795 Filed 3–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal And Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Program 

Project Grant Review. 

Date: March 24, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Helen Lin, Scientific 

Review Officer, Scientific Review Branch, 

National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, National 

Institutes of Health, 6701 Democracy Blvd., 

Suite 800, MSC 4872, Bethesda, MD 20892, 

301–594–4952, linh1@mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Small 

Grants Research Review. 

Date: April 7, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting) 

Contact Person: Eric H. Brown, Scientific 

Review Officer, Scientific Review Branch, 

National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, National 

Institutes of Health, 6701 Democracy Blvd., 

Suite 800, MSC 4872, Bethesda, MD 20892, 

(301) 594–4955, browneri@mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Rheumatic 

Disease Center Core Review. 

Date: April 13–14, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Michael L. Bloom, MBA, 

PhD, Scientific Review Officer, Scientific 

Review Branch, National Institute of 

Arthritis, Musculoskeletal and Skin Diseases, 

National Institutes of Health, 6701 

Democracy Blvd., Suite 800, MSC 4872, 

Bethesda, MD 20892, 301–594–4953, 

bloomm2@mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

mstockstill on DSKH9S0YB1PROD with NOTICES